Giorgio Mustacchi

Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial

Giorgio Mustacchi, Rita Ceccherini, Stefano Milani et al. · Annals of Oncology · 2003 · 203 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +10

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial

Joseph Gligorov, Dinesh Doval, José Bines et al. · The Lancet Oncology · 2014 · 126 citations

Breast Oncology, Oncology, Maintenance Capecitabine +7

Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly.

Giorgio Mustacchi, Stefano Milani, Alfonso M. Pluchinotta et al. · PubMed · 1995 · 89 citations

Surgical Oncology, Breast Oncology, Elderly Patients +17

Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast Cancer Patients: Results of an Italian Cooperative Study

Francesco Boccardo, A. Rubagotti, D. Amoroso et al. · Journal of Clinical Oncology · 2001 · 84 citations

Breast cancer in elderly women: a different reality? Results from the NORA study

Giorgio Mustacchi, Marina Elena Cazzaniga, P. Pronzato et al. · Annals of Oncology · 2007 · 61 citations · Full text

Nursing, Different Reality, Geriatric Oncology +12